COMP <GO>
POM vs BQ // EV/EBITDA & P/E VALUATION
POMDOCTOR LIMITED (Class A) (NASDAQ) VS. Boqii Holding Limited (Class A) (NYSE) • 15-METRIC TALLY: POM 2
— BQ 3
■ METRIC PARITY
LAST: $1.99 (+10.56%) • MKT CAP: $5.5M
valuation
—
LAST: $0.49 (-1.04%) • MKT CAP: $3.9M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (POM VS. BQ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | POM | BQ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 13.10% | 26.30% | -13.20 | BQ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -29.70% | -7.10% | -22.60 | BQ | /operating-margins <GO> |
| Net Profit Margin | — | -1.20% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -5.70% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 2/9 | -1.00 | BQ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 84.0 | 19.2 | +64.78 | POM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.5M | $3.9M | $1.6M | POM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | POM REV | BQ REV | POM GROSS % | BQ GROSS % | POM FCF | BQ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $57.2M | $61.0M | 13.1% | 26.3% | -$21.4M | -$4.4M |
| FY 2024 | — | $64.6M | — | 21.5% | — | -$9.7M |
| FY 2023 | — | $98.2M | — | — | — | -$3.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
POM // BETA —
BQ // BETA —